Pasar al contenido principal

Microbiota, health and probiotics

RYC-2016-19726

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of dietary isoflavone supplementation on the fecal microbiota and its metabolites in postmenopausal women

  • Guadamuro, Lucía
  • Azcárate-Peril, M. Andrea
  • Tojo, Rafael
  • Mayo Pérez, Baltasar
  • Delgado, Susana
Isoflavones are metabolized by components of the gut microbiota and can also modulate their composition and/or activity. This study aimed to analyze the modifications of the fecal microbial populations and their metabolites in menopausal women under dietary treatment with soy isoflavones for one month. Based on the level of urinary equol, the women had been stratified previously as equol-producers (n = 3) or as equol non-producers (n = 5). The composition of the fecal microbiota was assessed by high-throughput sequencing of 16S rRNA gene amplicons and the changes in fatty acid excretion in feces were analyzed by gas chromatography. A greater proportion of sequence reads of the genus Slackia was detected after isoflavone supplementation. Sequences of members of the family Lachnospiraceae and the genus Pseudoflavonifractor were significantly increased in samples from equol-producing women. Multivariable analysis showed that, after isoflavone treatment, the fecal microbial communities of equol producers were more like each other. Isoflavone supplementation increased the production of caproic acid, suggesting differential microbial activity, leading to a high fecal excretion of this compound. However, differences between equol producers and non-producers were not scored. These results may contribute to characterizing the modulating effect of isoflavones on the gut microbiota, which could lead to unravelling of their beneficial health effects., The research was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) (AGL-2014-57820-R) and Asturias Principality (GRUPIN14-137). The Microbiome Core Facility is supported in part by the NIH/National Institute of Diabetes and Digestive and Kidney Diseases grant P30 DK34987. L.G. was supported by a research contract of the FPI Program from MINECO (BES-2012-062502). S.D. was supported by a research contract from MINECO (RYC-2016- 19726).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ruminococcoides bili gen. Nov., sp. nov., a bile-resistant bacterium from human bile with autolytic behavior

  • Molinero, Natalia
  • Conti, Elena
  • Sánchez García, Borja
  • Walker, Alan W.
  • Margolles Barros, Abelardo
  • Duncan, Sylvia H.
  • Delgado, Susana
A strictly anaerobic, resistant starch-degrading, bile-tolerant, autolytic strain, IPLA60002, belonging to the family Ruminococcaceae, was isolated from a human bile sample of a liver donor without hepatobiliary disease. Cells were Gram-stain-positive cocci, and 16S rRNA gene and whole genome analyses showed that Ruminococcus bromii was the phylogenetically closest related species to the novel strain IPLA60002, though with average nucleotide identity values below 90%. Biochemically, the new isolate has metabolic features similar to those described previously for gut R. bromii strains, including the ability to degrade a range of different starches. The new isolate, however, produces lactate and shows distinct resistance to the presence of bile salts. Additionally, the novel bile isolate displays an autolytic phenotype after growing in different media. Strain IPLA60002 is phylogenetically distinct from other species within the genus Ruminococcus. Therefore, we propose on the basis of phylogenetic, genomic and metabolic data that the novel IPLA60002 strain isolated from human bile be given the name Ruminococcoides bili gen. nov., sp. nov., within the new proposed genus Ruminococcoides and the family Ruminococcaceae. Strain IPLA60002 (=DSM 110008=LMG 31505) is proposed as the type strain of Ruminococcoides bili., This study was supported by the: Tenovus (GB) Principle Award Recipient: ElenaConti Rural and Environment Science and Analytical Services Division (GB) (Award SG-RESAS) Principle Award Recipient: SylviaH. Duncan Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología (Award IDI/2018/000236) Principle Award Recipient: NotApplicable Ministerio de Economía y Competitividad (Award Ramón y Cajal” program (RYC-2016-19726)) Principle Award Recipient: SusanaDelgado Ministerio de Economía y Competitividad (Award FPI Predoctoral Grant BES-2014-068736) Principle Award Recipient: NataliaMolinero Ministerio de Economía y Competitividad (Award AGL2013-44761-P) Principle Award Recipient: AbelardoMargolles